A gene therapy from Regeneron, a pancreatic cancer medicine from Revolution Medicines and a porphyria drug from Disc Medicine ...
Phlow Corp., a leading American advanced pharmaceutical contract development and manufacturing organization (CDMO), today announced that the active pharmaceutical ingredient for ketamine ...
The IND is part of a pattern of progress on multiple fronts. Arcadia has raised $9.25M from investors including Sam Altman, Fred Ehrsam, and Dylan Field. The company has also secured a patent for ...
Broad-spectrum Antiviral NV-387 At Phase II Clinical Trial Stage – NV-387 Could Become a Revolutionary Antiviral for ...
The Food and Drug Administration on Tuesday quietly approved a generic form of mifepristone, one of the two medications used in most U.S. abortions. That makes the drug, from the company Evita ...
Breakthrough Therapy designation granted based on FDA’s review of available clinical evidence of safety and efficacy from all 12 patients treated ...
New Delhi: The Union government is set to make a critical change to healthcare policy by mandating that all hospitals include an Adverse Drug Reaction (ADR) reporting form as a compulsory part of the ...
Federal health officials are warning Americans to avoid sunscreens marketed in whipped, mousse and foam because they aren't approved as effective methods for applying the product. The Food and Drug ...
Omeros’ efforts to get its transplant drug to market have already suffered one FDA rejection. Now, the biotech’s second shot at approval has been pushed back by three months. Omeros had been given a ...
Dordaviprone is the first FDA-approved therapy for recurrent H3 K27M-mutant diffuse midline glioma, targeting an ultra-rare brain tumor in children and young adults. The approval was based on a 22% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback